Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 19.43% is 134% above its 5-year average of -57.78%, near the high end of its 5-year range (-283.88%–35.71%).
As of the fiscal period ended Tuesday, June 30, 2026. 212.07% above its 12-month average of -17.34%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 19.43%.
RETURN ON INVESTED CAPITAL (ROIC)
19.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-17.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-60.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-57.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+212.07%
CURRENT VS 3Y AVG
+132.09%
CURRENT VS 5Y AVG
+133.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+154.51%
vs the sector median at left
Q32 Bio Inc.
Market Cap
$241.27M
Return on Invested Capital (ROIC)
19.43%
TTM Avg
-17.34%
3Y Avg
-60.55%
5Y Avg
-57.78%
Market Cap
$241.95M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-8.11%
3Y Avg
-7.60%
5Y Avg
-6.24%
Market Cap
$239.92M
Return on Invested Capital (ROIC)
-43.69%
TTM Avg
-34.60%
3Y Avg
-35.16%
5Y Avg
-35.84%
Market Cap
$242.09M
Return on Invested Capital (ROIC)
-35.90%
TTM Avg
-35.20%
3Y Avg
-44.95%
5Y Avg
-38.58%
Market Cap
$243.49M
Return on Invested Capital (ROIC)
-69.76%
TTM Avg
-64.00%
3Y Avg
-45.05%
5Y Avg
-31.07%
Market Cap
$238.57M
Return on Invested Capital (ROIC)
1.38%
TTM Avg
-1.85%
3Y Avg
-13.83%
5Y Avg
-10.66%
Market Cap
$238.38M
Return on Invested Capital (ROIC)
-51.87%
TTM Avg
-45.51%
3Y Avg
-40.69%
5Y Avg
-46.57%
Market Cap
$237.81M
Return on Invested Capital (ROIC)
-7.08%
TTM Avg
-12.89%
3Y Avg
-21.42%
5Y Avg
-39.95%
Market Cap
$245.65M
Return on Invested Capital (ROIC)
-1718.59%
TTM Avg
-749.70%
3Y Avg
-566.74%
5Y Avg
-409.31%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Q32 Bio Inc. (QTTB) | $241.27M | 19.43% | -17.34% | -60.55% | -57.78% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.95M | N/A | -8.11% | -7.60% | -6.24% |
| Century Therapeutics, Inc. (IPSC)vs › | $239.92M | -43.69% | -34.60% | -35.16% | -35.84% |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $242.09M | -35.90% | -35.20% | -44.95% | -38.58% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $243.49M | -69.76% | -64.00% | -45.05% | -31.07% |
| High Tide Inc. (HITI)vs › | $238.57M | 1.38% | -1.85% | -13.83% | -10.66% |
| Quantum-Si incorporated (QSI)vs › | $238.38M | -51.87% | -45.51% | -40.69% | -46.57% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $237.81M | -7.08% | -12.89% | -21.42% | -39.95% |
| Galectin Therapeutics Inc. (GALT)vs › | $245.65M | -1718.59% | -749.70% | -566.74% | -409.31% |
| Invivyd, Inc. (IVVD)vs › | $236.07M | -59.90% | -142.39% | -118.24% | -103.50% |
ROIC
19.4%
ROE
31.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 19.43% |
| 2026-03-31 | 35.71% |
| 2025-12-31 | 29.47% |
| 2025-09-30 | -82.23% |
| 2025-06-30 | -89.06% |
| 2025-03-31 | -91.81% |
| 2024-12-31 | -83.71% |
| 2024-09-30 | -84.40% |
| 2024-06-30 | -61.25% |
| 2024-03-31 | -45.50% |
| 2023-12-31 | -142.66% |
| 2023-09-30 | -153.76% |
| 2023-06-30 | -37.42% |
| 2023-03-31 | -42.24% |
| 2022-12-31 | -283.88% |
| 2022-09-30 | -30.49% |
| 2022-06-30 | -27.10% |
| 2022-03-31 | -45.58% |
| 2021-12-31 | -49.27% |
| 2021-09-30 | -43.04% |
| 2021-06-30 | -37.15% |
| 2021-03-31 | -43.28% |
| 2020-12-31 | -53.48% |
| 2020-09-30 | -58.98% |
| 2020-06-30 | -53.52% |
| 2020-03-31 | -44.33% |
| 2019-12-31 | -36.87% |
| 2019-09-30 | -35.15% |
| 2019-06-30 | -27.56% |
| 2019-03-31 | -35.14% |
| 2018-12-31 | -26.35% |
| 2018-09-30 | -21.39% |
| 2018-06-30 | -16.89% |
